ArticleHematology, transfusion and cell therapy

Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19.

Marcela Hernández-Coronado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.